Español
Today we talk in our blog about another of the rare diseases that the OLIGOFASTX consortium is working on: Fuchs’ Corneal Endothelial Endothelial Dystrophy (FECD). This pathology affects approximately 4% of the population over 40 years of age, and much more women than men. Results from miRNA expression profiling in FECD endothelial cells demonstrates widespread […]
Category Archives: Rare diseases
13
Apr
Apr
Rare diseases (affecting fewer than 1 in 2,000 people) are an emerging global public health priority. Given their high heterogeneity and the need to provide individualized medicine for small patient populations, they have become a challenge for healthcare systems and biopharmaceutical research. This post is about one of these diseases that affect young children from […]
28
Feb
Feb
Oligofastx is a project born from a need: to offer a therapeutic pathway based on the development of specific oligonucleotides for certain rare diseases for which there is no solution at the moment. I feel this is our leit-motiv and sign of identity, we could not miss, of course, to join the celebration of Rare […]
16
Jan
Jan
Cancer cachexia is a complex metabolic syndrome characterized by marked loss of body weight, anorexia, asthenia, sarcopenia, and anemia. It is the most common manifestation of advanced malignant cancer, leading to death. Approximately half of all cancer patients experience cachexia and the prevalence is over 80% in terminally ill patients, with cachexia being responsible for […]
10
Jan
Jan
Perhaps the definition is not the most accurate, but in reality a rare disease does nothing more than denominate a pathology that has not yet been studied, analyzed and against which there is, for the time being, no solution. The complexity of the processes to reach social development solutions for the improvement of patients’ quality […]
26
Sep
Sep
Every last Sunday of September is celebrated the International Retinitis Pigmentosa Day, one of the rare and genetic diseases of the retina. Aware of the complications that the disease can bring, from Oligofastx we work together in the research and development of solutions based on the development of oligonucleotides to reach an effective treatment. This […]
15
Sep
Sep
Today is International Myotonic Dystrophy Day, a rare disease with no treatment or cure to date. Although Myotonic Dystrophy is not within the Oligofastx project, it is one of the diseases on which Arthex Biotech (Oligofastx partner company) is researching and working to find a therapeutic solution. Specifically, Arthex is developing an experimental RNA-based drug […]